https://clinicaltrials.gov/ct2/show/NCT01580293?type=Intr&cond=hemophilia&lupd_s=03%2F01%2F2019&lupd_d=14
Condition : Hemophilia A
Intervention : Biological: BAY94-9027
Sponsor : Bayer
Active, not recruiting
A Trial Investigating Safety and Efficacy of Treatment With BAY94-9027 in Severe Hemophilia A
NCT01580293
Thu, 19 Apr 2012 12:00:00 EDT
Last Update Posted: 03/15/19 11:40AM